TARO-BORTEZOMIB

Google image searchProduct monograph

Active ingredient

bortezomib (bortezomib mannitol boronic ester), 2.5 MG/VIAL

DIN: 02511932

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 18-JUL-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XG — Proteasome inhibitors (ATC, ATC/DDD)
• L01XG01 — BORTEZOMIB (ATC/DDD)

Reference brand drug: Velcade

External Links for Taro-Bortezomib

Search on Google

• Taro-Bortezomib side effects
• Taro-Bortezomib dosage
• bortezomib side effects
• bortezomib dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-bortezomib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.